Molecular Determinants for the Binding of the Highly Infectious SARS-CoV-2 Omicron (BA.1) Variant to the Human ACE2 Receptor
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, continually undergoes mutation, leading to variants with altered pathogenicity and transmissibility. The Omicron variant (B.1.1.529), first identified in South Africa in 2021, has become the dominant strai...
Saved in:
| Main Authors: | Majed S. Aljohani, Pawan Bhatta, Xiche Hu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Physchem |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-7167/5/1/8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
by: Minrun Duan, et al.
Published: (2023-12-01) -
Subtle Changes at the RBD/hACE2 Interface During SARS-CoV-2 Variant Evolution: A Molecular Dynamics Study
by: Aria Gheeraert, et al.
Published: (2025-04-01) -
Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
by: Kotou Sangare, et al.
Published: (2025-01-01) -
Electronic Interactions Between the Receptor-Binding Domain of Omicron Variants and Angiotensin-Converting Enzyme 2: A Novel Amino Acid–Amino Acid Bond Pair Concept
by: Puja Adhikari, et al.
Published: (2025-05-01) -
The presence of neutralizing antibodies against omicron subvariants among a vaccinated cohort at one year after the first dose of vaccination in Malaysia
by: Eida Nurhadzira Muhammad, et al.
Published: (2025-06-01)